Advancell Release: Start of in-Patient Clinical Trials With NT-KO-003, the First Neuroprotective Drug for Multiple Sclerosis Without Immunosuppressive Effects
7/19/2011 10:28:41 AM
More...
|
Advancell Announces Promising Phase I/IIa Results with Acadra(R) in CLL
2/15/2011 10:30:19 AM
More...
|
Advancell Introduces In London Its Cellular Reagent Isocyp-Toxtm, Which Predicts Hepatic Toxicity In Future Drugs
6/15/2009 1:45:06 PM
More...
|
ADMEcell Enters into Agreement with Advancell
3/13/2009 7:32:50 AM
More...
|
ADMEcell Enters into an Agreement To Exclusively Manufacture and Distribute Advancell’s CacoReady(TM) System throughout North America
2/23/2009 12:47:03 PM
More...
|
Protherics PLC and Advancell Start Acadra(TM) Clinical Study in B-cell Chronic Lymphocytic Leukaemia
1/11/2008 8:44:12 AM
More...
|